Inventor
PARK MIN HEE
KR22 patents
⚠️ This page may combine multiple inventors who share the name “PARK MIN HEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND
9 patentsUS11766444B2Sep 26, 2023
Pharmaceutical composition for preventing or treating degenerative brain disorders including HDL-APOM-S1P as active ingredient
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations62
US12398109B2Aug 26, 2025
2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting ASM activity, and use thereof
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11279744B2Mar 22, 2022
Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11007228B2May 18, 2021
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US12570617B2Mar 10, 2026
Use of triazole compound as ghrelin receptor agonist
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US12545745B2Feb 10, 2026
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10543254B2Jan 28, 2020
Composition containing neuropeptide Y for inhibiting side effects of anticancer agents
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10323064B2Jun 18, 2019
Peptides for treating bone diseases and use thereof
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10143727B2Dec 4, 2018
Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION
3 patentsUS11242529B2Feb 8, 2022
Method for treating a neurological disorder comprising administering ASM inhibitors
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION0 citations61
US10682373B2Jun 16, 2020
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION0 citations51
US10098855B2Oct 16, 2018
Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION1 citations51
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND
2 patentsUS9724334B1Aug 8, 2017
Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND4 citations72
US9724394B2Aug 8, 2017
Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND0 citations49